178 related articles for article (PubMed ID: 35082519)
1. Correlation Between Apelin and Collateral Circulation in Patients with Middle Cerebral Artery Occlusion and Moyamoya Disease.
Wu H; Xia C; Li R; Tao C; Tang Q; Hu W
Int J Gen Med; 2022; 15():699-709. PubMed ID: 35082519
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases.
Hu W; Jiang W; Ye L; Tian Y; Shen B; Wang K
Sci Rep; 2017 Jul; 7(1):5452. PubMed ID: 28710384
[TBL] [Abstract][Full Text] [Related]
3. Assessment of plasma soluble Tie-2 level to distinguish moyamoya disease from atherosclerotic cerebrovascular disease and predict postoperative neovascularization.
Chen T; Wei W; Zhang J; Yu J; Xu S; Wu D; Li X; Chen J
J Neurosurg; 2023 Dec; 139(6):1705-1714. PubMed ID: 37347656
[TBL] [Abstract][Full Text] [Related]
4. TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease.
Chen Y; Tang M; Li H; Liu H; Wang J; Huang J
Front Neurol; 2022; 13():899470. PubMed ID: 35873760
[TBL] [Abstract][Full Text] [Related]
5. Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease.
Liu SM; Gao G; Hao FB; Liu ST; Yang RM; Zhang HD; Wang MJ; Zou ZX; Yu D; Zhang Q; Guo QB; Wang XP; Fu HG; Li JJ; Han C; Duan L
Stroke Vasc Neurol; 2024 Mar; ():. PubMed ID: 38460971
[TBL] [Abstract][Full Text] [Related]
6. Expression of hypoxia-inducing factor-1 alpha and endoglin in intimal hyperplasia of the middle cerebral artery of patients with Moyamoya disease.
Takagi Y; Kikuta K; Nozaki K; Fujimoto M; Hayashi J; Imamura H; Hashimoto N
Neurosurgery; 2007 Feb; 60(2):338-45; discussion 345. PubMed ID: 17290185
[TBL] [Abstract][Full Text] [Related]
7. Combined gene therapy with vascular endothelial growth factor plus apelin in a chronic cerebral hypoperfusion model in rats.
Hiramatsu M; Hishikawa T; Tokunaga K; Kidoya H; Nishihiro S; Haruma J; Shimizu T; Takasugi Y; Shinji Y; Sugiu K; Takakura N; Date I
J Neurosurg; 2017 Sep; 127(3):679-686. PubMed ID: 28009234
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients.
Arai N; Horiguchi T; Takahashi S; Nakahara T; Akiyama T; Jinzaki M; Yoshida K
Neurosurg Rev; 2020 Oct; 43(5):1323-1329. PubMed ID: 31444715
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 and Prostaglandin E2 are Associated with Middle Cerebral Artery Occlusion and Hemorrhage in Patients with Moyamoya Disease.
Zhang J; Xiong Z; Wang S; He Y; Sun S; Wu X; Wang L; Zhang H; You C; Wang Y; Chen J
Curr Neurovasc Res; 2016; 13(1):68-74. PubMed ID: 26503024
[TBL] [Abstract][Full Text] [Related]
10. Contribution of Apelin-17 to Collateral Circulation Following Cerebral Ischemic Stroke.
Jiang W; Hu W; Ye L; Tian Y; Zhao R; Du J; Shen B; Wang K
Transl Stroke Res; 2019 Jun; 10(3):298-307. PubMed ID: 29916125
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repair.
Kanamori F; Yokoyama K; Ota A; Yoshikawa K; Karnan S; Maruwaka M; Shimizu K; Ota S; Uda K; Araki Y; Okamoto S; Maesawa S; Wakabayashi T; Natsume A
Neurosurg Focus; 2021 Sep; 51(3):E3. PubMed ID: 34469870
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative Effects of Combined Revascularization Surgery on Abnormal Collateral Channels in Moyamoya Disease.
Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Kuroda S
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105624. PubMed ID: 33516067
[TBL] [Abstract][Full Text] [Related]
13. Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease.
Zhang JJ; Xiong ZW; Wang S; Sun SJ; Wang H; Wu XL; Wang L; Zhang HQ; You C; Wang Y; Chen JC
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):181-185. PubMed ID: 27072959
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease.
Takagi Y; Kikuta K; Sadamasa N; Nozaki K; Hashimoto N
Neurosurgery; 2006 Oct; 59(4):894-900; discussion 900-1. PubMed ID: 17038954
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
[TBL] [Abstract][Full Text] [Related]
16. Differential Expression of Vascular Endothelial Growth Factor-A
Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma apelin level and coronary collateral circulation.
Akboga MK; Akyel A; Sahinarslan A; Demirtas CY; Yayla C; Boyaci B; Yalcin R
Atherosclerosis; 2014 Aug; 235(2):289-94. PubMed ID: 24905139
[TBL] [Abstract][Full Text] [Related]
18. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
[TBL] [Abstract][Full Text] [Related]
19. Histological features of middle cerebral arteries from patients treated for Moyamoya disease.
Takagi Y; Kikuta K; Nozaki K; Hashimoto N
Neurol Med Chir (Tokyo); 2007 Jan; 47(1):1-4. PubMed ID: 17245006
[TBL] [Abstract][Full Text] [Related]
20. Impaired functional recovery of endothelial colony-forming cells from moyamoya disease in a chronic cerebral hypoperfusion rat model.
Choi SA; Chong S; Kwak PA; Moon YJ; Jangra A; Phi JH; Lee JY; Park SH; Kim SK
J Neurosurg Pediatr; 2018 Nov; 23(2):204-213. PubMed ID: 30668528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
